Patents by Inventor Kejian Wang

Kejian Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12208345
    Abstract: The present disclosure provides a grid system, including a grid body and supports, where the grid body includes a water intake module, a filtering module, a residue scraping module, a residue pressing module, and a water discharge module; the filtering module is disposed at a middle-upper part of the grid body, the water intake module and the residue pressing module are organically coupled at a lower part of the filtering module, and the water intake module includes a water inlet and a water distribution area; the filtering module includes a water retaining platform, an inflow water guide plate, screen plate areas, and a central water retaining weir; the residue scraping module includes scrapers, a driving motor, a support frame, a residue inlet, and a guide rail; the residue pressing module includes a squeezing cylinder, a motor, and a residue outlet.
    Type: Grant
    Filed: July 29, 2024
    Date of Patent: January 28, 2025
    Assignee: North China Municipal Engineering Design & Research Institute Co., Ltd.
    Inventors: Yongli Sun, Pengfeng Li, Min Yang, Kejian Sui, Yaxiong Wang, Jiaju Li, Wei Zhang
  • Publication number: 20250019401
    Abstract: An antimicrobial peptide Bolespleenin of Boleophthalmus pectinirostris and application thereof, and an amino acid sequence of the antimicrobial polypeptide Bolespleenin is shown in SEQ ID NO.01.
    Type: Application
    Filed: May 10, 2024
    Publication date: January 16, 2025
    Inventors: Kejian WANG, Yuqi BAI, Fangyi CHEN, Hui PENG, Huiyun CHEN
  • Patent number: 12173296
    Abstract: The present disclosure discloses a method for using plant heterosis. The method comprises the following steps: S1, transforming the meiosis of germ cells of hybrids into mitosis-like so as to obtain gametes whose genotype and chromosome ploidy are consistent with hybrids by using gene mutation or gene engineering technology; and S2, influencing and involving in the development of gametes or embryos in plants by using gene mutation and gene engineering technology, wherein a protein involved is MTL protein.
    Type: Grant
    Filed: March 6, 2019
    Date of Patent: December 24, 2024
    Assignee: China National Rice Research Institute
    Inventors: Kejian Wang, Chun Wang
  • Publication number: 20240409591
    Abstract: The present invention relates to the field of biotechnology and plant breeding, and in particular relates to a method using plant cell proliferation regulator gene to induce haploid, and a use thereof in plant breeding. In the present invention, expression profiles of unfertilized egg cells of rice and rice embryos 5 days after fertilization are analyzed, and 2 genes are discovered to have relatively high expression, OsCPRO1 and OsCPRO2. The research shows that these two genes can be utilized to induce the production of haploid descendants. Specifically, a promoter specifically expressed in egg cells controls the gene to convert a plant, obtaining induced haploid plant material of a positive transgenic plant. Furthermore, the induced haploid plant material can be combined with a MiMe system to obtain apomixes material, and thereby generate clone seeds.
    Type: Application
    Filed: June 6, 2023
    Publication date: December 12, 2024
    Inventors: Kejian WANG, Chun WANG, Xin WEI
  • Patent number: 12102086
    Abstract: An antimicrobial peptide Spampcin56-86from Scylla paramamosain is provided. A molecular formula of the antimicrobial peptide Spampcin56-86 is C154H256N54O33S3, and an amino acid sequence of the antimicrobial peptide Spampcin56-86 is shown in SEQ ID NO: 01.
    Type: Grant
    Filed: August 24, 2023
    Date of Patent: October 1, 2024
    Assignee: XIAMEN UNIVERSITY
    Inventors: Kejian Wang, Manyu Jiang, Fangyi Chen
  • Publication number: 20240138406
    Abstract: An antimicrobial peptide Scyampcin44-63, a formula of the antimicrobial peptide Scyampcin44-63 is C113H188N30O24S2, and an amino acid sequence of the antimicrobial peptide Scyampcin44-63 is SEQ ID NO: 01 with the C-terminus being amidated.
    Type: Application
    Filed: December 28, 2023
    Publication date: May 2, 2024
    Inventors: Kejian WANG, Ying ZHOU, Fangyi CHEN
  • Publication number: 20240097947
    Abstract: Embodiments of this application disclose a data interface equalization adjustment method and apparatus, a device, and a storage medium, and relate to the field of data interface technologies. The method includes: A second device determines equalization parameter indication information of a first transmitter TX on a first data interface. The second device sends a first equalization training sequence block ETSB to a corresponding RX on the first data interface through a TX on a second data interface, where the first ETSB carries the equalization parameter indication information and equalization target indication information, and the equalization target indication information indicates that the first TX is an equalization target. The first device determines the equalization target to be the first TX based on the equalization target indication information, and adjusts an equalization parameter of the first TX to an equalization parameter indicated by the equalization parameter indication information.
    Type: Application
    Filed: November 28, 2023
    Publication date: March 21, 2024
    Applicant: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Shibin Xu, Kejian Wang, Fei Luo, Jiankang Li
  • Patent number: 11912988
    Abstract: Provided are a method and a kit for constructing a simplified genomic library. The method comprises: performing a non-specific amplification on a whole genome with a first pair of primers to obtain random amplified fragments; performing a specific amplification on the random amplified fragments with a second pair of primers to obtain the simplified genomic library.
    Type: Grant
    Filed: January 26, 2018
    Date of Patent: February 27, 2024
    Assignee: China National Rice Research Institute
    Inventors: Kejian Wang, Qing Liu
  • Publication number: 20230404076
    Abstract: A Spampcin56-86 is provided. A molecular formula of Spampcin56-86 is C154H256N54O33S3, and an amino acid sequence of Spampcin56-86 is shown in SEQ ID NO: 01.
    Type: Application
    Filed: August 24, 2023
    Publication date: December 21, 2023
    Inventors: Kejian WANG, Manyu JIANG, Fangyi CHEN
  • Publication number: 20230049934
    Abstract: A data interface sleep and wakeup method includes receiving data information sent by a second electronic device, where the data information includes sleep information, and setting, based on the sleep information, at least one data interface to either a sleep state or a wakeup state.
    Type: Application
    Filed: October 19, 2022
    Publication date: February 16, 2023
    Inventors: Kejian Wang, Yongwei Chen, Yinhai Pan, Yongyao Li, Maobin Fan
  • Patent number: 11512120
    Abstract: The present disclosure discloses an antimicrobial peptide Scyreprocin of Scylla paramamosain and a method thereof, wherein an amino acid sequence of the antimicrobial peptide Scyreprocin comprises a sequence shown in SEQ ID NO 01, and the antimicrobial peptide is expressed and purified by using genetic engineering technology. The recombinant antimicrobial peptide Scyreprocin has advantages of wide antimicrobial spectrum, good antimicrobial effect, and rapid germicidal rate, shows great application significance, and has good application in preparation of antimicrobial agents. The recombinant antimicrobial peptide Scyreprocin has no cytotoxicity to mouse hepatocytes AML12, human liver cells L02, and can be safely used for medical treatment or can be used as a feed composition.
    Type: Grant
    Filed: April 14, 2021
    Date of Patent: November 29, 2022
    Assignee: Xiamen University
    Inventors: Kejian Wang, Ying Yang, Fangyi Chen, Yanchao Chen, Huiyun Chen, Hui Peng
  • Publication number: 20220296677
    Abstract: A peptide Scyreprocin of Scylla paramamosain, an amino acid sequence of the peptide Scyreprocin is SEQ ID NO 01.
    Type: Application
    Filed: May 18, 2022
    Publication date: September 22, 2022
    Inventors: Kejian Wang, Ying Yang, Fangyi Chen, Huiyun Chen, Hui Peng
  • Patent number: 11299514
    Abstract: The present disclosure discloses an antimicrobial peptide AS-hepc3(48-56) of Acanthopagrus schlegelii and method thereof. A molecular formula of the antimicrobial peptide AS-hepc3(48-56) is C48H86N24O10S3, and an amino acid sequence of the antimicrobial peptide AS-hepc3(48-56) is SEQ ID NO: 01.
    Type: Grant
    Filed: July 12, 2021
    Date of Patent: April 12, 2022
    Assignee: Xiamen University
    Inventors: Kejian Wang, Depeng Zhu, Hui Peng, Fangyi Chen, Huiyun Chen
  • Publication number: 20220088551
    Abstract: Device for creating an emulsion consisting of a dispersed phase in the form of drops in a continuous phase, the device comprising: a motion generator (11) in order to put into motion at least one first fluid (3) intended to form the dispersed phase; a first channel (21) inside which the first fluid (3) put into motion can flow, the first channel (21) extending towards an output orifice (23) through which the first fluid is injected into at least one second fluid (5) intended to form the continuous phase; a variation system (40) for varying the internal volume (Vi) of the first channel (21) over time.
    Type: Application
    Filed: January 27, 2020
    Publication date: March 24, 2022
    Applicant: Fluigent
    Inventors: Kejian Wang, Clémence Vergne, Lionel Matthys
  • Patent number: 11254717
    Abstract: Provided is an antimicrobial peptide Sparamosin from Scylla paramamosain. The Sparamosin mature peptide and its functional domain Sparamosin26-54 were synthesized by solid-phase synthesis with a purity of over 95%. Both Sparamosin and Sparamosin26-54 exhibit strong antimicrobial activity. More importantly, Sparamosin26-54 has strong antifungal activity and could inhibit the growth of a variety of yeasts and filamentous fungi. Based on the potent antimicrobial activities of Sparamosin and Sparamosin26-54, both peptides could be developed as alternatives for conventional antibiotics, antimicrobial agents, feed additives in aquaculture and livestock, preservatives, and mold inhibitors.
    Type: Grant
    Filed: July 31, 2020
    Date of Patent: February 22, 2022
    Assignee: Xiamen University
    Inventors: Kejian Wang, Yanchao Chen, Fangyi Chen, Ying Yang, Hui Peng, Huiyun Chen
  • Publication number: 20210363537
    Abstract: The present disclosure discloses a method for using plant heterosis. The method comprises the following steps: S1, transforming the meiosis of germ cells of hybrids into mitosis-like so as to obtain gametes whose genotype and chromosome ploidy are consistent with hybrids by using gene mutation or gene engineering technology; and S2, influencing and involving in the development of gametes or embryos in plants by using gene mutation and gene engineering technology, wherein a protein involved is MTL protein.
    Type: Application
    Filed: March 6, 2019
    Publication date: November 25, 2021
    Inventors: Kejian WANG, Chun WANG
  • Publication number: 20210340179
    Abstract: The present disclosure discloses an antimicrobial peptide AS-hepc3(48-56) of Acanthopagrus schlegelii and method thereof. A molecular formula of the antimicrobial peptide AS-hepc3(48-56) is C48H86N24O10S3, and an amino acid sequence of the antimicrobial peptide AS-hepc3(48-56) is SEQ ID NO: 01.
    Type: Application
    Filed: July 12, 2021
    Publication date: November 4, 2021
    Inventors: Kejian WANG, Depeng ZHU, Hui PENG, Fangyi CHEN, Huiyun CHEN
  • Publication number: 20210317172
    Abstract: The present disclosure discloses an antimicrobial peptide Scyreprocin of Scylla paramamosain and a method thereof, wherein an amino acid sequence of the antimicrobial peptide Scyreprocin comprises a sequence shown in SEQ ID NO 01, and the antimicrobial peptide is expressed and purified by using genetic engineering technology. The recombinant antimicrobial peptide Scyreprocin has advantages of wide antimicrobial spectrum, good antimicrobial effect, and rapid germicidal rate, shows great application significance, and has good application in preparation of antimicrobial agents. The recombinant antimicrobial peptide Scyreprocin has no cytotoxicity to mouse hepatocytes AML12, human liver cells L02, and can be safely used for medical treatment or can be used as a feed composition.
    Type: Application
    Filed: April 14, 2021
    Publication date: October 14, 2021
    Inventors: Kejian WANG, Ying YANG, Fangyi CHEN, Yanchao CHEN, Huiyun CHEN, Hui PENG
  • Publication number: 20210061865
    Abstract: Provided is an antimicrobial peptide Sparamosin from Scylla paramamosain. The Sparamosin mature peptide and its functional domain Sparamosin26-54 were synthesized by solid-phase synthesis with a purity of over 95%. Both Sparamosin and Sparamosin26-54 exhibit strong antimicrobial activity. More importantly, Sparamosin26-54 has strong antifungal activity and could inhibit the growth of a variety of yeasts and filamentous fungi. Based on the potent antimicrobial activities of Sparamosin and Sparamosin26-54, both peptides could be developed as alternatives for conventional antibiotics, antimicrobial agents, feed additives in aquaculture and livestock, preservatives, and mold inhibitors.
    Type: Application
    Filed: July 31, 2020
    Publication date: March 4, 2021
    Inventors: Kejian WANG, Yanchao CHEN, Fangyi CHEN, Ying YANG, Hui PENG, Huiyun CHEN
  • Patent number: D904230
    Type: Grant
    Filed: January 28, 2019
    Date of Patent: December 8, 2020
    Assignee: CH-AUTO TECHNOLOGY CO., LTD.
    Inventors: Kejian Wang, Fanlei Meng, Julien Stephane Monborgne